Jordan vs Montserrat: Tuberculosis patients living with HIV receiving antiretroviral therapy
Jordan
0 patients
in 2021
Montserrat
0 patients
in 2019
Jordan rank
141st
Montserrat rank
141st
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Jordan
- Montserrat
How they compare
Jordan currently reports 0 patients against 0 patients in Montserrat, a difference of 0 patients.
The two have swapped places 6 times across 13 shared years of data; in 2003 it was Montserrat ahead.
Jordan ranks 141st and Montserrat ranks 141st of 183 countries.
Across the 2 decades both report, Jordan averaged higher in 1 and Montserrat in 1.
Head to head by decade
| Decade | Jordan | Montserrat | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 patients | 0.5 patients | 0.5 patients | Montserrat |
| 2010s | 0.5556 patients | 0 patients | 0.5556 patients | Jordan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Jordan or Montserrat?
- Jordan, at 0 patients against 0 patients in Montserrat as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Jordan and Montserrat?
- 0 patients, with Jordan ahead.
- How many years of comparable data are there for Jordan and Montserrat?
- 13 years are reported by both, from 2003 to 2019.
- How do Jordan and Montserrat rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Jordan ranks 141st and Montserrat ranks 141st of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.